ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1971

Muscle Pathology in Patients with Primary Biliary Cholangitis

Jose Cesar Milisenda1, Iago Pinal-Fernandez2, Katherine Pak2, Maria Casal-Dominguez3, Yaiza Duque-Jaimez4, Gloria Garrabou1, Sandra Muñoz-Braceras5, Mariona Guitart-Manpel1, Jose Jiram Torres-Ruiz5, Ester Tobias4, Maria Dolores Cano4, Iban Aldecoa4, Josep Maria Grau1 and Andrew Mammen3, 1Muscle Research Unit, Internal Medicine Service, Hospital Clinic, Barcelona, Spain, 2National Institutes of Health, Bethesda, MD, 3NIH, Bethesda, MD, 4Hospital Clínic de Barcelona, Barcelona, Spain, 5Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

Meeting: ACR Convergence 2023

Keywords: autoimmune diseases, Muscle Biology, Muscle Function, Musculoskeletal Examination, Myopathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1945–1972) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease that primarily affects middle-aged women. It is characterized by elevated serum alkaline phosphatase levels, the presence of antimitochondrial antibodies (AMAs), and cholangiopathy on liver pathology. Fatigue is a common symptom experienced by up to 80% of patients at the time of diagnosis and during follow-up. Unfortunately, current treatments have not been effective in alleviating fatigue. The objective of this study is to evaluate fatigue and investigate any potential muscle involvement in PBC patients.

Methods: We conducted a single-center, cross-sectional study involving 50 patients who suffered from both PBC and fatigue. Muscle biopsies were performed to whom presented muscle weakness. Histopathological analysis was made and also RNA sequencing was performed on muscle biopsies (n=10) as well as 33 normal muscle biopsies. Muscle biopsies were stained for human immunoglobulin and PDC-E2.

Results: Abnormal accumulation of mitochondria in the subsarcolemal region was observed in both optical and electron microscopy. A significant set of immunoglobulin genes was specifically found to be overexpressed in CBP, while over 50 genes related to mitochondrial function were predominantly underexpressed. In muscle biopsies positive for AMA-M2, immunoglobulins were localized in the cytoplasm and colocalized with PDC-E2.

Conclusion: Based on these findings, we can conclude that there is muscular involvement in PBC, and we hypothesise it is likely mediated by AMA-M2 antibodies.

Supporting image 1

ME. Mitochondrial accumulation at subsarcolemmal region

Supporting image 2

Dotplot for GSEA (PBC cases)


Disclosures: J. Milisenda: None; I. Pinal-Fernandez: None; K. Pak: None; M. Casal-Dominguez: None; Y. Duque-Jaimez: None; G. Garrabou: None; S. Muñoz-Braceras: None; M. Guitart-Manpel: None; J. Torres-Ruiz: None; E. Tobias: None; M. Cano: None; I. Aldecoa: None; J. Grau: None; A. Mammen: None.

To cite this abstract in AMA style:

Milisenda J, Pinal-Fernandez I, Pak K, Casal-Dominguez M, Duque-Jaimez Y, Garrabou G, Muñoz-Braceras S, Guitart-Manpel M, Torres-Ruiz J, Tobias E, Cano M, Aldecoa I, Grau J, Mammen A. Muscle Pathology in Patients with Primary Biliary Cholangitis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/muscle-pathology-in-patients-with-primary-biliary-cholangitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/muscle-pathology-in-patients-with-primary-biliary-cholangitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology